Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) When Co-administered With High Dose of Atorvastatin in Patients With Primary Hypercholesterolemia

NCT01288469 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

92

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: Alirocumab
DRUG: Placebo (for alirocumab)
DRUG: Atorvastatin
DRUG: Placebo (for atorvastatin)

Sponsor

Sanofi

Collaborators

[object Object]